Quantcast
Search For Better Biofuels Microbes Leads To The Human Gut

Search For Better Biofuels Microbes Leads To The Human Gut

Diana Yates, University of Illinois at Urbana-Champaign Scientists have scoured cow rumens and termite guts for microbes that can efficiently break down plant cell walls for the production of next-generation biofuels, but some of the best...

Latest Gut flora Stories

2014-10-01 12:31:15

Rebiotix lead drug candidate RBX2660 (microbiota suspension) assessed in PUNCH CD study ROSEVILLE, Minn., Oct. 1, 2014 /PRNewswire/ -- Rebiotix Inc. announced this morning that results of PUNCH CD, a Phase 2 study of the company's lead product candidate, RBX2660 (microbiota suspension), will be presented in three posters at the American College of Gastroenterology (ACG) Annual Scientific Meeting in Philadelphia from October 17-22. The following poster will be presented on Monday, October 20,...

2014-09-30 23:08:01

ReNew Life Formulas, America’s #1 Probiotic Brand, introduces Ultimate Flora™ Men’s Complete Probiotic 90 Billion to their award-winning line of Ultimate Flora probiotics. Ultimate Flora Men’s Complete is a high-potency, multi-strain probiotic formulated to promote digestive, immune, and colon health in men.* Clearwater, FL (PRWEB) September 30, 2014 Bifidobacteria, the primary bacteria found in the large intestine (colon), declines with age, poor diet, and stress, so a high...

2014-09-28 23:00:59

DailyGossip.org publishes a review to the Candida Crusher program, a new guide that promises to teach patients how to overcome this health problem. Denver, Colorado (PRWEB) September 28, 2014 Daily Gossip writes in its review that Candida Crusher is a 730 page book released by Eric Bakker, a popular naturopathic doctor with more than 25 years of experience treating patients suffering from this health problem. Bakker has treated over 15,000 Candida patients. Eric Bakker’s book presents...

2014-09-23 12:29:47

CHICAGO, Sept. 23, 2014 /PRNewswire-USNewswire/ -- C Diff Foundation is proud to present the 2014 "Raising C.difficile Awareness" conference. Join us November 4(th) at 8 a.m. - 5 p.m. at the University of Illinois at Chicago, Student Center, West 828 S. Wolcott Avenue, Thompson Room, Chicago, IL. World renowned topic experts will be presenting data for C. difficile and Hospital-Acquired Infection (HAI) prevention, treatments, and environmental safety. To view the conference details,...

2014-09-19 12:25:43

DUBLIN, Sept. 19, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Human Microbiome (Diabetes, Obesity, Autoimmune, Cancer, Diarrhea, Mental Disorder) Market - Forecast to 2023" report to their offering. http://photos.prnewswire.com/prnvar/20130307/600769 For the purposes of this report, the human microbiome market is segmented by application, disease, product, and geography. The human microbiome market is expected to be valued as $294 million in 2019 and...

2014-09-18 23:07:02

The human microbiome market is divided into three major segments, namely, application, disease, and product. http://www.marketsandmarkets.com/Market-Reports/human-microbiome-market-37621904.html (PRWEB) September 18, 2014 The "Human Microbiome Market by Disease (Diabetes, Obesity, Autoimmune, Cancer, Diarrhea, Mental Disorder), Application (Therapeutic, Diagnostic) & by Product (Probiotic, Prebiotic, Food, Medical Food, Supplement, Device, Drug) –Global Forecast to 2023",...

2014-09-17 12:27:55

Rebiotix microbiota-based drug candidate used to assess a non-antibiotic approach to an urgent public health threat ROSEVILLE, Minn., Sept. 17, 2014 /PRNewswire/ -- Rebiotix Inc. announced this morning that results of the Phase 2 study of the company's lead product candidate, RBX2660 (microbiota suspension) will be presented in two posters and a podium presentation during the IDWeek 2014 conference in Philadelphia from October 8-12. PUNCH CD study results will be presented during the poster...

2014-09-17 04:21:26

GLASGOW, Scotland, September 17, 2014 /PRNewswire/ -- First antibacterial with a new mode of action from a truly novel class of anti-infective in over a decade MGB Biopharma, a biopharmaceutical company developing a truly novel class of anti-infectives, announces today that it has secured GBP4.0m ($6.4m) to advance the development of its lead antibacterial, MGB-BP-3, against a range of Gram-positive infections including Clostridium...

2014-09-10 16:25:54

DALLAS, September 10, 2014 /PRNewswire/ -- According to the new market research report "Human Microbiome Market by Disease (Diabetes, Obesity, Autoimmune, Cancer, Diarrhea, Mental Disorder), Application (Therapeutic, Diagnostic) & by Product (Probiotic, Prebiotic, Food, Medical Food, Other Supplements, Device, Drug) - Global Forecast to 2023", published by MarketsandMarkets, provides a detailed overview of the major drivers, restraints, challenges, opportunities, current...

2014-09-08 16:25:18

Phase I/II study also demonstrated SER-109 restoration of a diverse, healthy microbiome CAMBRIDGE, Mass., Sept. 8, 2014 /PRNewswire/ -- Seres Health, a clinical-stage therapeutics company developing novel treatments for diseases related to the human microbiome, today announced final data for its single-arm, open-label clinical trial of SER-109, its first-in-field, oral microbiome therapeutic. SER-109, a mixture of bacterial spores, is designed for the treatment of recurrent...


Latest Gut flora Reference Libraries

Large Intestine
2013-04-30 14:11:04

The large intestine is the organ that follows the small intestine but is the last part of the digestive tract before the waste leaves the body. Formation and Orientation The small intestine is on average about five feet long. It is composed of four distinct structural parts; the cecum, colon, and anus. The cecum is the part of the large intestine that comes first. It is separated into three parts. The taeniae coli are three bands of smooth muscle. The haustra are bulges caused by...

72_04c5b3879bb85672771defa94bb4ac91
2011-04-15 14:54:29

Escherichia coli is a Gram-negative rod-shaped bacterium that is commonly found in the lower intestine of warm-blooded organisms. Most strains are harmless; however, some such as O157:H7 can cause food poisoning in humans and are often responsible for product recalls. The normal flora of the gut normally contains the harmless strains and often provide K2 to the body. They are not always confined to the intestine and have the ability to survive briefly outside of the body. It grows easily...

0_9f897835bb09adc2a84fda23893d87f8
2011-04-15 13:50:01

Clostridium difficile, also known as "CDF/cdf", or "C. diff", is a Gram-positive bacteria of the genus Clostridium that causes severe diarrhea and other intestinal disease when competing bacteria in the gut flora are wiped out by antibiotics. They are anaerobic, spore-forming rods and is the most serious cause of antibiotic-associated diarrhea and potentially to pseudomembranous colitis. C. difficile bacteria naturally resides in the gut of a small percentage of the adult population. Others...

More Articles (3 articles) »
Word of the Day
cacodemon
  • An evil spirit; a devil.
  • A nightmare.
  • In astrology, the twelfth house of a scheme or figure of the heavens: so called from its signifying dreadful things, such as secret enemies, great losses, imprisonment, etc.
'Cacodemon' comes from a Greek term meaning 'evil genius.'
Related